- call +1-201-465-4211
- email sales@mrinsights.biz
An A1C test is a blood test that reflects your average blood glucose levels over the past 3 months. The A1C test is sometimes called the hemoglobin A1C, HbA1c, glycated hemoglobin, or glycohemoglobin test. Hemoglobin is the part of a red blood cell that carries oxygen to the cells.
Scope of the Report:
This report studies the Hemoglobin A1c Monitoring market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hemoglobin A1c Monitoring market by product type and applications/end industries.
Determining glycated hemoglobin levels assure healthcare professionals about the patient’s blood glucose levels. This test is used for diagnosing and monitoring hemoglobin A1c levels in the diabetic patients. As the A1c test reflects the average amount of glucose for the past two to three months, it is considered to be more reliable than traditional blood glucose tests. Due to increasing incidence of diabetes and growing awareness of better management of diabetes, the global hemoglobin A1c testing devices market is expected to develop rapidly in the years to come. Nowadays, medical professionals usually prescribe HbA1c test over conventional blood glucose tests to patients.
The global Hemoglobin A1c Monitoring market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hemoglobin A1c Monitoring.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer Healthcare Diabetes Care (US)
Abbott Laboratories (US)
Roche Diagnostics (Switzerland)
Axis-Shield plc (UK)
Beckman Coulter, Inc. (US)
Bio-Rad Laboratories Inc (US)
Diazyme Laboratories Inc. (US)
EKF Diagnostics Holdings Plc (UK)
HEMOCUE(r) AB (Sweden)
Infopia Co. Ltd. (South Korea)
Menarini Diagnostics Ltd. (UK)
Siemens Healthcare Diagnostics (Germany)
Tosoh Bioscience, Inc (US)
Trinity Biotech plc (Ireland)
ARKRAY, Inc. (Japan)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ion-exchange
High-performance liquid chromatography (HPLC)
Immunoassay
Boronate affinity chromatography
Direct enzymatic assay
Market Segment by Applications, can be divided into
HbA1c Laboratory Testing
HbA1c Point of Care Testing
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hemoglobin A1c Monitoring Market Overview
1.1 Product Overview and Scope of Hemoglobin A1c Monitoring
1.2 Classification of Hemoglobin A1c Monitoring by Types
1.2.1 Global Hemoglobin A1c Monitoring Revenue Comparison by Types (2017-2023)
1.2.2 Global Hemoglobin A1c Monitoring Revenue Market Share by Types in 2017
1.2.3 Ion-exchange
1.2.4 High-performance liquid chromatography (HPLC)
1.2.5 Immunoassay
1.2.6 Boronate affinity chromatography
1.2.7 Direct enzymatic assay
1.3 Global Hemoglobin A1c Monitoring Market by Application
1.3.1 Global Hemoglobin A1c Monitoring Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 HbA1c Laboratory Testing
1.3.3 HbA1c Point of Care Testing
1.4 Global Hemoglobin A1c Monitoring Market by Regions
1.4.1 Global Hemoglobin A1c Monitoring Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hemoglobin A1c Monitoring Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hemoglobin A1c Monitoring Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hemoglobin A1c Monitoring Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hemoglobin A1c Monitoring Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hemoglobin A1c Monitoring Status and Prospect (2013-2023)
1.5 Global Market Size of Hemoglobin A1c Monitoring (2013-2023)
2 Manufacturers Profiles
2.1 Bayer Healthcare Diabetes Care (US)
2.1.1 Business Overview
2.1.2 Hemoglobin A1c Monitoring Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Healthcare Diabetes Care (US) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories (US)
2.2.1 Business Overview
2.2.2 Hemoglobin A1c Monitoring Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories (US) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche Diagnostics (Switzerland)
2.3.1 Business Overview
2.3.2 Hemoglobin A1c Monitoring Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Diagnostics (Switzerland) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.4 Axis-Shield plc (UK)
2.4.1 Business Overview
2.4.2 Hemoglobin A1c Monitoring Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Axis-Shield plc (UK) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.5 Beckman Coulter, Inc. (US)
2.5.1 Business Overview
2.5.2 Hemoglobin A1c Monitoring Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Beckman Coulter, Inc. (US) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Rad Laboratories Inc (US)
2.6.1 Business Overview
2.6.2 Hemoglobin A1c Monitoring Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Rad Laboratories Inc (US) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.7 Diazyme Laboratories Inc. (US)
2.7.1 Business Overview
2.7.2 Hemoglobin A1c Monitoring Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Diazyme Laboratories Inc. (US) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.8 EKF Diagnostics Holdings Plc (UK)
2.8.1 Business Overview
2.8.2 Hemoglobin A1c Monitoring Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 EKF Diagnostics Holdings Plc (UK) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.9 HEMOCUE(r) AB (Sweden)
2.9.1 Business Overview
2.9.2 Hemoglobin A1c Monitoring Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 HEMOCUE(r) AB (Sweden) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.10 Infopia Co. Ltd. (South Korea)
2.10.1 Business Overview
2.10.2 Hemoglobin A1c Monitoring Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Infopia Co. Ltd. (South Korea) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.11 Menarini Diagnostics Ltd. (UK)
2.11.1 Business Overview
2.11.2 Hemoglobin A1c Monitoring Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Menarini Diagnostics Ltd. (UK) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.12 Siemens Healthcare Diagnostics (Germany)
2.12.1 Business Overview
2.12.2 Hemoglobin A1c Monitoring Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Siemens Healthcare Diagnostics (Germany) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.13 Tosoh Bioscience, Inc (US)
2.13.1 Business Overview
2.13.2 Hemoglobin A1c Monitoring Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Tosoh Bioscience, Inc (US) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.14 Trinity Biotech plc (Ireland)
2.14.1 Business Overview
2.14.2 Hemoglobin A1c Monitoring Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Trinity Biotech plc (Ireland) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
2.15 ARKRAY, Inc. (Japan)
2.15.1 Business Overview
2.15.2 Hemoglobin A1c Monitoring Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 ARKRAY, Inc. (Japan) Hemoglobin A1c Monitoring Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hemoglobin A1c Monitoring Market Competition, by Players
3.1 Global Hemoglobin A1c Monitoring Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hemoglobin A1c Monitoring Players Market Share
3.2.2 Top 10 Hemoglobin A1c Monitoring Players Market Share
3.3 Market Competition Trend
4 Global Hemoglobin A1c Monitoring Market Size by Regions
4.1 Global Hemoglobin A1c Monitoring Revenue and Market Share by Regions
4.2 North America Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
4.3 Europe Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
4.5 South America Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
5 North America Hemoglobin A1c Monitoring Revenue by Countries
5.1 North America Hemoglobin A1c Monitoring Revenue by Countries (2013-2018)
5.2 USA Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
5.3 Canada Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
5.4 Mexico Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
6 Europe Hemoglobin A1c Monitoring Revenue by Countries
6.1 Europe Hemoglobin A1c Monitoring Revenue by Countries (2013-2018)
6.2 Germany Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
6.3 UK Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
6.4 France Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
6.5 Russia Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
6.6 Italy Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hemoglobin A1c Monitoring Revenue by Countries
7.1 Asia-Pacific Hemoglobin A1c Monitoring Revenue by Countries (2013-2018)
7.2 China Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
7.3 Japan Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
7.4 Korea Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
7.5 India Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
8 South America Hemoglobin A1c Monitoring Revenue by Countries
8.1 South America Hemoglobin A1c Monitoring Revenue by Countries (2013-2018)
8.2 Brazil Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
8.3 Argentina Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
8.4 Colombia Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hemoglobin A1c Monitoring by Countries
9.1 Middle East and Africa Hemoglobin A1c Monitoring Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
9.3 UAE Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
9.4 Egypt Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
9.6 South Africa Hemoglobin A1c Monitoring Revenue and Growth Rate (2013-2018)
10 Global Hemoglobin A1c Monitoring Market Segment by Type
10.1 Global Hemoglobin A1c Monitoring Revenue and Market Share by Type (2013-2018)
10.2 Global Hemoglobin A1c Monitoring Market Forecast by Type (2018-2023)
10.3 Ion-exchange Revenue Growth Rate (2013-2023)
10.4 High-performance liquid chromatography (HPLC) Revenue Growth Rate (2013-2023)
10.5 Immunoassay Revenue Growth Rate (2013-2023)
10.6 Boronate affinity chromatography Revenue Growth Rate (2013-2023)
10.7 Direct enzymatic assay Revenue Growth Rate (2013-2023)
11 Global Hemoglobin A1c Monitoring Market Segment by Application
11.1 Global Hemoglobin A1c Monitoring Revenue Market Share by Application (2013-2018)
11.2 Hemoglobin A1c Monitoring Market Forecast by Application (2018-2023)
11.3 HbA1c Laboratory Testing Revenue Growth (2013-2018)
11.4 HbA1c Point of Care Testing Revenue Growth (2013-2018)
12 Global Hemoglobin A1c Monitoring Market Size Forecast (2018-2023)
12.1 Global Hemoglobin A1c Monitoring Market Size Forecast (2018-2023)
12.2 Global Hemoglobin A1c Monitoring Market Forecast by Regions (2018-2023)
12.3 North America Hemoglobin A1c Monitoring Revenue Market Forecast (2018-2023)
12.4 Europe Hemoglobin A1c Monitoring Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hemoglobin A1c Monitoring Revenue Market Forecast (2018-2023)
12.6 South America Hemoglobin A1c Monitoring Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hemoglobin A1c Monitoring Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hemoglobin A1c Monitoring Picture
Table Product Specifications of Hemoglobin A1c Monitoring
Table Global Hemoglobin A1c Monitoring and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
